Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

The University of Hong Kong (HKU)

Status: Enrolling

Conditions: Hematopoietic Stem Cell Transplant (HSCT)

Study type: Observational

Funder types: Other

Identifiers

NCT06702111

ALLO-HSCT-001

Details and patient eligibility

About

To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients aged 18 years or older who received allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Exclusion criteria

• participant who is unable to give informed consent in a prospective cohort.

Trial design

1,000 participants in 1 patient group

All patients receiving allogeneic HSCT at Queen Mary Hospital, Hong Kong